Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab effectively controls SLE disease activity and reduces steroid use.

Certain skin symptoms can help detect and manage systemic lupus.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Certain foods and supplements can help treat skin diseases alongside medication.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

CGF therapy may help hair regrowth and improve scars in DLE patients.

SLE patients often face depression and anxiety due to physical changes, with African-American and Hispanic patients having higher unmet psychological needs.

A woman with lupus had blood cell destruction, treated successfully with medication.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

SLE and DM can coexist but are rare and need careful evaluation.

Oral ulcers are common in SLE patients and often link to other symptoms.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Stem-cell therapy shows promise for skin conditions but needs more research.

New therapies are being developed that target integrin pathways to treat various diseases.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Two children with lysinuric protein intolerance showed symptoms similar to lupus.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.